Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.
暂无分享，去创建一个
A. Bacigalupo | W. Arcese | F. Fagioli | G. Milone | C. Selleri | S. Sica | S. Leotta | C. Uderzo | S. Dallorso | R. Scimé | M. V. van Lint | S. Guidi | A. Locasciulli | L. Cudillo | N. Mordini | B. Bruno